The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.
Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock closed at a record high.

Employee engagement in U.S. hits lowest point in 15 years
Fast Company · 45 minutes ago
Inside giant homebuilder D.R. Horton’s bet on robotic homebuilding
Fast Company · 45 minutes ago
Is Binance Being Hacked? $2 Billion Outflow Puts Customer Funds in Question
BeInCrypto · 56 minutes ago


